Angiotensin II generation by mast cell α- and β-chymases

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1480, Issue 1-2, 2000, Pages 245-257

  Caughey, George H ^a   Raymond, Wilfred W ^a   Wolters, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin; Chymase; Dipeptidylpeptidase I; Mast cell

Indexed keywords

ANGIOTENSIN; CHYMASE; DIPEPTIDYL PEPTIDASE I;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; ENZYME PURIFICATION; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; CELL DEGRANULATION; CHROMATOGRAPHY, AFFINITY; CHYMASES; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; ISOENZYMES; MAST CELLS; MICE; MODELS, MOLECULAR; RATS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES;

CANIS FAMILIARIS; PRIMATES;

EID: 0034647653     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(00)00076-5     Document Type: Article

References (54)

1. G.H. Caughey, Mast cell chymases and tryptases: Phylogeny, family relations and biogenesis. In: G.H. Caughey (Ed.), Mast Cell Proteases in Immunology and Biology, Marcel Dekker, New York, 1995, pp. 305-329.
2. Chandrasekharan U.M., Sanker S., Glynias M.J., Karnik S.S., Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science. 271:1996;502-505.
3. Gurish M.F., Nadeau J.H., Johnson K.R., McNeil H.P., Grattan K.M., Austen K.F., Stevens R.L. A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14. J. Biol. Chem. 268:1993;11372-11379.
4. Lutzelschwab C., Pejler G., Aveskogh M., Hellman L. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J. Exp. Med. 185:1997;13-29.
5. Schechter N.M., Fraki J.E., Geesin J.C., Lazarus G.S. Human skin chymotryptic proteinase. Isolation and relation to cathepsin G and rat mast cell proteinase I. J. Biol. Chem. 258:1983;2973-2978.
6. Caughey G.H., Zerweck E.H., Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J. Biol. Chem. 266:1991;12956-12963.
7. Urata H., Kinoshita A., Perez D.M., Misono K.S., Bumpus F.M., Graham R.M., Husain A. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 266:1991;17173-17179.
8. Caughey G.H., Schaumberg T.H., Zerweck E.H., Butterfield J.H., Hanson R.D., Silverman G.A., Ley T.J. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics. 15:1993;614-620.
9. Reilly C.F., Tewksbury D.A., Schechter N.B., Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257:1982;8619-8622.
10. Wintroub B.U., Schechter N.B., Lazarus G.S., Kaempfer C.E., Schwartz L.B. Angiotensin I conversion by human and rat chymotryptic proteinases. J. Invest. Dermatol. 83:1984;336-339.
11. Takai S., Shiota N., Kobayashi S., Matsumura E., Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett. 412:1997;86-90.
12. Hoit B.D., Shao Y., Kinoshita A., Gabel M., Husain A., Walsh R.A. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon. J. Clin. Invest. 95:1995;1519-1527.
13. Urata H., Boehm K.D., Philip A., Kinoshita A., Gabrovsek J., Bumpus F.M., Husain A. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J. Clin. Invest. 91:1993;1269-1281.
14. Shiota N., Okunishi H., Fukamizu A., Sakonjo H., Kikumori M., Nishimura T., Nakagawa T., Murakami K., Miyazaki M. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett. 323:1993;239-242.
15. Shiota N., Okunishi H., Takai S., Mikoshiba I., Sakonjo H., Shibata N., Miyazaki M. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation. 99:1999;1084-1090.
16. Balcells E., Meng Q.C., Johnson W.H. Jr., Oparil S., Dell'Italia L.J. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am. J. Physiol. 273:1997;H1769-H1774.
17. Akasu M., Urata H., Kinoshita A., Sasaguri M., Ideishi M., Arakawa K. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension. 32:1998;514-520.
18. Zisman L.S., Abraham W.T., Meixell G.E., Vamvakias B.N., Quaife R.A., Lowes B.D., Roden R.L., Peacock S.J., Groves B.M., Raynolds M.V., et al. Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway. J. Clin. Invest. 96:1995;1490-1498.
19. Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA. 83:1986;4464-4468.
20. Dell'Italia L.J., Meng Q.C., Balcells E., Wei C.C., Palmer R., Hageman G.R., Durand J., Hankes G.H., Oparil S. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J. Clin. Invest. 100:1997;253-258.
21. Wei C.C., Meng Q.C., Palmer R., Hageman G.R., Durand J., Bradley W.E., Farrell D.M., Hankes G.H., Oparil S., Dell'Italia L.J. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation. 99:1999;2583-2589.
22. Suzuki H., Caughey G.H., Gao X.-P., Rubinstein I. Mast cell chymase-like protease(s) modulates Escherichia coli lipopolysaccharide-induced vasomotor dysfunction in skeletal muscle in vivo. J. Pharmacol. Exp. Ther. 284:1998;1156-1164.
23. Hisada Y., Sugaya T., Yamanouchi M., Uchida H., Fujimura H., Sakurai H., Fukamizu A., Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest. 103:1999;627-635.
24. McGrath M.E., Mirzadegan T., Schmidt B.F. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9Å Biochemistry. 36:1997;14318-14324.
25. Pereira P.J.B., Wang Z.M., Rubin H., Huber R., Bode W., Schechter N.M., Strobl S. The 2.2 Å crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J. Mol. Biol. 286:1999;163-173.
26. Remington S.J., Woodbury R.G., Reynolds R.A., Matthews B.W., Neurath H. The structure of rat mast cell protease II at 1.9-Å resolution. Biochemistry. 27:1988;8097-8145.
27. Yamamoto D., Shiota N., Takai S., Ishida T., Okunishi H., Miyazaki M. Three-dimensional molecular modeling explains why catalytic function for angiotensin-I is different between human and rat chymases. Biochem. Biophys. Res. Commun. 242:1998;158-163.
28. Caughey G.H., Viro N.F., Lazarus S.C., Nadel J.A. Purification and characterization of dog mastocytoma chymase. Identification of an octapeptide conserved in chymotryptic leukocyte proteases. Biochim. Biophys. Acta. 952:1988;142-149.
29. Caughey G.H., Raymond W.W., Vanderslice P. Dog mast cell chymase: Molecular cloning and characterization. Biochemistry. 29:1990;5166-5171.
30. Caughey G.H., Blount J.L., Koerber K.L., Kitamura M., Fang K.C. Cloning and expression of the dog mast cell α-chymase gene. J. Immunol. 159:1997;4367-4375.
31. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-β J. Immunol. 162:1999;5528-5535.
32. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., Hanahan D. Inflammatory mast cells upregulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13:1999;1382-1397.
33. Raymond W.W., Hartmann T., Koerber K.K., Wolters P.J., Kitamura M., Ruoss S.J., Caughey G.H. Expression, activation and characterization of recombinant human mast cell pro-α-chymase. FASEB J. 12:1998;A897.
34. Wolters P.J., Raymond W.W., Blount J.L., Caughey G.H. Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. J. Biol. Chem. 273:1998;15514-15520.
35. Caughey G.H., Lazarus S.C., Viro N.F., Gold W.M., Nadel J.A. Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines. Immunology. 63:1988;339-344.
36. I.H. Segel, Biochemical Calculations, John Wiley, New York, 1976.
37. Peitsch M.C. ProMod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:1996;274-279.
38. Pejler G., Karlström A. Thrombin is inactivated by mast cell secretory granule chymase. J. Biol. Chem. 268:1993;11817-11822.
39. Serafin W.E., Sullivan T.P., Conder G.A., Ebrahimi A., Marcham P., Johnson S.S., Austen K.F., Reynolds D.S. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J. Biol. Chem. 266:1991;1934-1941.
40. Huang R., Blom T., Hellman L. Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases. Eur. J. Immunol. 21:1991;1611-1621.
41. McEuen A.R., Ashworth D.M., Walls A.F. The conversion of recombinant human mast cell prochymase to enzymatically active chymase by dipeptidyl peptidase I is inhibited by heparin and histamine. Eur. J. Biochem. 253:1998;300-308.
42. Schechter N.M., Sprows J.L., Schoenberger O.L., Lazarus G.S., Cooperman B.S., Rubin H. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J. Biol. Chem. 264:1989;21308-21315.
43. Huang R., Hellman L. Genes for mast-cell serine protease and their molecular evolution. Immunogenetics. 40:1994;397-414.
44. McNeil H.P., Austen K.F., Somerville L.L., Gurish M.F., Stevens R.L. Molecular cloning of the mouse mast cell protease-5 gene. A novel secretory granule protease expressed early in the differentiation of serosal mast cells. J. Biol. Chem. 266:1991;20316-20322.
45. Takai S., Shiota N., Yamamoto D., Okunishi H., Miyazaki M. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci. 58:1996;591-597.
46. Shiota N., Fukamizu A., Okunishi H., Takai S., Murakami K., Miyazaki M. Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts. Biochem. J. 333:1998;417-424.
47. Tam E.K., Caughey G.H. Degradation of airway neuropeptides by human lung tryptase. Am. J. Respir. Cell Mol. Biol. 3:1990;27-32.
48. Kinoshita A., Urata H., Bumpus F.M., Husain A. Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart. J. Biol. Chem. 266:1991;19192-19197.
49. Das M., Soffer R. Pulmonary angiotensin-converting enzyme. Structural and catalytic properties. J. Biol. Chem. 250:1875;6762-6768.
50. Schechter N.M., Irani A.M., Sprows J.L., Abernethy J., Wintroub B., Schwartz L.B. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J. Immunol. 145:1990;2652-2661.
51. Caughey G.H., Leidig F., Viro N.F., Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244:1988;133-137.
52. Murakami M., Karnik S.S., Husain A. Human prochymase activation. A novel role for heparin in zymogen processing. J. Biol. Chem. 270:1995;2218-2223.
53. Bastos M., Maeji N.J., Abeles R.H. Inhibitors of human heart chymase based on a peptide library. Proc. Natl. Acad. Sci. USA. 92:1995;6738-6742.
54. Owen C.A., Campbell E.J. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Immunol. 160:1998;1436-1443.